5[4]Sovage D G.Anfman kh ina tim ib messy lafea new oral,targeted therapy[J].N Engl J Med,2002,346(10):683
6Druker BJ,Talpaz M,Resta DJ,et al.Eifficacy and safety of a specific inhibitor of the BCR/ABL tyrosine kinase in chronic myeloid leukemia[J].N Engl J Med,2001,344(14):1031-1037.
8Thambi P,Sausville EA.STI571(imatinib mesylate):the tale of targeted therapy[J].Anticancer Drugs,2002,13(2):111-114.
9O'Dwyer ME,Mauro MJ,Druker BJ.Recent advancements in the treatment of chronic myelogenous leukemia[J].Ann Rev Med,2002,53:369-38.
10Clarkson B,Strife A,Wisniewski D,et al.Chronic myelogenous leukemia as a paradigm of eary cancer and possible curatine st rategies[J].Leukemia,2003,17(7):1211-1262.
